Showing results (6341-6350 of 25,889) with videos related to
Sort By:
Pageof 2,589
Anticancer Research|December 27, 2011
PCA3 score vs PSA free/total accuracy in prostate cancer diagnosis at repeat saturation biopsyPietro Pepe, Francesco AragonaAnticancer Research|December 16, 2014
Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsyStefano De Luca, Roberto Passera, Enrico Bollito, et al.Anticancer Research|January 30, 2022
Prognostic Significance of 3-Month Prostate-specific Antigen Level Following Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate CancerYujiro Nagata, Takuo Matsukawa, Ikko Tomisaki, et al.Anticancer Research|March 12, 1998
Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P)A Berruti, S Cerutti, G Fasolis, et al.Anticancer Research|August 5, 2006
Serum testosterone: A potentially adjunct screening test for the assessment of the risk of prostate cancer among men with modestly elevated PSA values (> or =3.0 and <10.0 ng/ml)Dimitrios Karamanolakis, Theocharis Lambou, John Bogdanos, et al.Anticancer Research|March 1, 1990
Tumour adjacent macrophage function in experimental tumoursS B Holmberg, L Hafström, L JacobssonAnticancer Research|July 11, 2006
Individualization of the subcutaneous amifostine dose during hypofractionated / accelerated radiotherapyMichael I Koukourakis, Ioannis Abatzoglou, Leonidas Sivridis, et al.Anticancer Research|July 3, 2017
Effects of Pulsed Electromagnetic Fields on Breast Cancer Cell Line MCF 7 Using Absorption SpectroscopyDominic Z Alcantara, Ian Jerry S Soliman, Romeric F Pobre, et al.Anticancer Research|June 29, 2026
Metabolic Reprogramming and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Mechanisms and Therapeutic StrategiesDohee Ahn, Kyung-Chul ChoiAnticancer Research|June 29, 2026
Clinical Outcomes of Pola-R-CHP Therapy in Patients Aged >80 Years With Diffuse Large B-Cell LymphomaYuta Baba, Satoshi Fukumura, Seira Tanai, et al.Pageof 2,589